A recent study in PNAS implicates alterations in the brain's glutamate signaling in people with PTSD. Neuroimaging revealed increased levels of mGluR5 in those with post traumatic stress disorder. Researchers report drugs that can reduce mGluR5 function could help reduce fear, stress and other symptoms of PTSD.
